Core Capital Management & Research’s Johnson & Johnson JNJ Stock Holding History

Core Capital Management & Research’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09M	Buy	+4,002	New	+$933K	0.57%	36

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Core Capital Management & Research's JNJ Position: Q2 2026 in Review

Core Capital Management & Research opened a new position in Johnson & Johnson (JNJ) in Q2 2026: 4,002 shares worth $1.09M. The stake represents 0.57% of the portfolio and ranks #36 among its holdings.

4,694 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Core Capital Management & Research held 4,002 shares of Johnson & Johnson worth $1.09M as of Q2 2026.
Johnson & Johnson was a new Core Capital Management & Research position in Q2 2026.
Johnson & Johnson made up 0.57% of Core Capital Management & Research's portfolio in Q2 2026, its #36 holding.
4,694 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Core Capital Management & Research's 13F filing for Q2 2026, filed 9 Sep 2026.